Legal & General Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-56,190
Closed -$18.3M 3560
2024
Q1
$18.3M Buy
56,190
+582
+1% +$143K 0.01% 867
2023
Q4
$10.6M Sell
55,608
-6,430
-10% -$1.22M ﹤0.01% 1102
2023
Q3
$12.4M Buy
62,038
+806
+1% +$191K ﹤0.01% 979
2023
Q2
$17.5M Buy
61,232
+2,576
+4% +$715K 0.01% 879
2023
Q1
$12.7M Buy
58,656
+2,134
+4% +$416K ﹤0.01% 953
2022
Q4
$11.6M Buy
56,522
+2,986
+6% +$755K ﹤0.01% 987
2022
Q3
$14.9M Sell
53,536
-2,921
-5% -$743K 0.01% 887
2022
Q2
$10.8M Buy
56,457
+24,149
+75% +$4.26M ﹤0.01% 1038
2022
Q1
$6.7M Buy
32,308
+418
+1% +$68.9K ﹤0.01% 1364
2021
Q4
$5.69M Buy
31,890
+1,377
+5% +$272K ﹤0.01% 1502
2021
Q3
$6.28M Buy
30,513
+6,188
+25% +$1.21M ﹤0.01% 1425
2021
Q2
$4.62M Buy
24,325
+2,905
+14% +$475K ﹤0.01% 1574
2021
Q1
$2.79M Buy
21,420
+12,276
+134% +$1.47M ﹤0.01% 1835
2020
Q4
$949K Sell
9,144
-36
-0.4% -$3.12K ﹤0.01% 2130
2020
Q3
$696K Sell
9,180
-963
-9% -$54.6K ﹤0.01% 2129
2020
Q2
$480K Buy
10,143
+6,016
+146% +$248K ﹤0.01% 2179
2020
Q1
$146K Sell
4,127
-1,144
-22% -$45.4K ﹤0.01% 2328
2019
Q4
$232K Buy
5,271
+4,171
+379% +$154K ﹤0.01% 2364
2019
Q3
$33K Hold
1,100
﹤0.01% 2926
2019
Q2
$63K Buy
+1,100
New +$53.4K ﹤0.01% 2681

Other funds holding SWAV

Legal & General Group's SWAV Position: Q2 2024 in Review

Legal & General Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 56,190 shares — an estimated $18.3M sold.

Legal & General Group first reported a position in SWAV in Q2 2019 and held it in 20 quarters. The position peaked at $18.3M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Legal & General Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 56,190 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $18.3M.
  • Legal & General Group first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 20 quarters.
  • Legal & General Group's Shockwave Medical, Inc. Common Stock position peaked at $18.3M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.